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BACKGROUND 
In December 2011 the Danish Government  
issued a new plan of action for chronic disease 
management in the Danish counties and among other  
things granted  DKK 100 mill to set up new positions as  
case managers to help vulnerable elderly patients.  
However, no precise job description was provided and  
the Danish counties still request further evidence for  
the effect of case management (CM). 
 
This study aims to investigate the consequences  
and costs of providing local CM to patients  
suffering from COPD. 
STUDY DESIGN: By use of the UK Medical Research Councils (MRC) frame-
work for development of complex interventions1, the design of the case 
manager job description and the RCT was determined through a systemat-
ic literature review, interviews with key persons and discussions in a spe-
cialist-comprised steering group. CM was designed to encompass coordi-
nation of care, facilitation of relevant health- and social services and 
promotion of patient self-care through advocacy and education. The RCT 
was powered to detect the effect of CM on hospital admissions. Secondary 
measures include mortality, quality of life, self-care and cost-effectiveness 
of CM vs. usual care. 150 COPD patients are equally randomized into two 
groups after referral to pulmonary rehabilitation at the local rehabilitation 
center in Aalborg County, Denmark. The control group will receive usual 
care, whereas the interventional group will receive CM besides their usual 
care. Each patient is followed for 12 months.  
DATA COLLECTION: The questionnaires SF-12, EQ-5D, Saint-George´s 
Respiratory Questionnaire (SG-RQ) and The Patient-Activation-Measure 
(PAM-13) are completed at baseline and 12 months, and data for the 
economic evaluation are collected alongside trial. Prospectively collected 
data from national population-based medical registries; including the 
Danish National Registry of Patients, are used to estimate events and 
resource usage. 
PRELIMINARY STATUS: The RCT terminates January 2014, and we hope 
to achieve a reduction in hospital admissions and overall mortality, see an 
improvement in the patient´s quality of life and ability to provide self-care, 
and to demonstrate the cost-effectiveness of providing CM to COPD pa-
tients in a Danish setting. The study is expected to provide further insight 
to the future organization of CM, and if being cost-effective, the interven-
tion could be applied to comparable healthcare settings. 
PATIENT BASELINE CHARACTERISTICS: 
*A weekly alcohol consumption of > 7 units for women and > 14 units for men poses a poten-
tial health risk2,3. †Sedentary/Lightly active= Light activity 0-4h/week; Moderately active = Light 
activity > 4h/week; Very active = strenuous activity 2-4h/week. ‡SGRQ scores go from 0 (better 
health status) to 100 (worse health status). ¶PAM-13 scores are divided into four levels of 
activation; Level 1 – Starting to take a role (score ≤47.0), Level 2 – Building knowledge and 
confidence (score 47.1-55.1), Level 3 – Taking action (score 55.2-67.0), Level 4 – Maintaining 
behaviors (score≥67.1). #SF-12 scores go from 0 (worse health status) to 100 (better health 
status). 
 
  Intervention Control p-value 
Male, n (%) 37 (48.7) 27 (37.0) 0.149 
Age, years (±SD) 69.1 (8.3) 69.5 (8.5) 0.749 
Living alone, n (%) 29 (38.2) 34 (46.6) 0.298 
Employed, n (%) 11 (14.5) 4 (5.5) 0.101 
Educational level, n (%) 
- Primary/secondary school or less 
- Vocational education 
- Higher education 
  
38 (50.0) 
22 (28.9) 
16 (21.1) 
  
39 (53.4) 
18 (24.7) 
16 (21.9) 
  
0.641 
Chronic comorbidities, n (%) 
- Diabetes 
- Heart disease 
- Osteoporosis 
  
8 (10.5) 
47 (61.8) 
15 (19.7) 
  
9 (12.3) 
39 (53.4) 
21 (28.8) 
  
0.729 
0.298 
0.198 
Smoking status, n (%) 
- Current 
- Former 
  
17 (22.4) 
56 (73.7) 
  
19 (26.0) 
49 (67.1) 
  
0.594 
Alcohol consumption> 
health guidelines, n (%)* 
12 (20.7) 11 (22.9) 0.782 
Level of physical activity, n (%)† 
- Sedentary/lightly active 
- Moderately active 
- Very active 
  
11 (14.5) 
61 (80.3) 
4 (5.3) 
  
12 (16.4) 
57 (78.1) 
4 (5.5) 
  
0.304 
BMI, kg/m2 (±SD) 26.3 (5.3) 26.3 (5.6) 0.966 
FEV1, l (median, P25-P75) 1.1 (0.9-1.6) 1.2 (0.9-1.5) 0.838 
FEV1/FVC, % (±SD) 53.3 (12.8) 55.2 (13.4) 0.372 
MRC dyspnea scale  
(median, P25-P75) 
3 (3-3.5) 3 (3-3) 0.765 
EQ-5D (median, P25-P75) 0.8 (0.7-1) 0.8 (0.6-0.8) 0.515 
SGRQ (median, P25-P75) ‡ 
- Symptoms component 
- Activities component 
- Impact component 
  
56.0 (35.4-67.0) 
67.6 (44.3-91.6) 
27.3 (13.6-53.1) 
  
52.6 (37.3-60.2) 
67.6 (44.8-84.2) 
30.3 (18.9-51.7) 
  
0.329 
0.793 
0.648 
PAM-13 (±SD) ¶ 59.6 (12.4) 60.9 (14.5) 0.566 
SF-12 (±SD) # 
- Physical score 
- Mental score 
  
39.3 (9.6) 
51.8 (10.5) 
  
37.7 (9.6) 
50.3 (10.3) 
  
0.304 
0.396 
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